ArticleEClinicalMedicine2021

Corrigendum to "Nitazoxanide superiority to placebo to treat moderate COVID-19 - A Pilot prove of concept randomized double-blind clinical trial." [EClinicalMedicine 37 (2021) 100981].

Vinicius Fontanesi Blum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.